SlideShare une entreprise Scribd logo
1  sur  79
Télécharger pour lire hors ligne
PULMONARY FUNCTION
TEST
Lung Volumes and Capacities
PFT tracings have:
 Four Lung volumes: tidal
volume, inspiratory reserve
volume, expiratory reserve
volume, and residual
volume
 Five capacities:, inspiratory
capacity, expiratory
capacity, vital capacity,
functional residual capacity,
and total lung capacity
Addition of 2 or more volumes comprise a capacity.
Lung Volumes
• Tidal Volume (TV): volume of air
inhaled or exhaled with each
breath during quiet breathing (6-
8 ml/kg)
• Inspiratory Reserve Volume
(IRV): maximum volume of air
inhaled from the end-inspiratory
tidal position.(1900-3300ml)
• Expiratory Reserve Volume
(ERV): maximum volume of air
that can be exhaled from resting
end-expiratory tidal position.(
700-1000ml).
Lung Volumes
• Residual Volume (RV):
– Volume of air remaining
in lungs after maximium
exhalation (20-25 ml/kg)
(1700-2100ml)
– Indirectly measured
(FRC-ERV)
– It can not be measured
by spirometry
Lung Capacities
• Total Lung Capacity (TLC): Sum of
all volume compartments or
volume of air in lungs after
maximum inspiration (4-6 L)
• Vital Capacity (VC): TLC minus RV
or maximum volume of air exhaled
from maximal inspiratory level.
(60-70 ml/kg) (3100-4800ml)
• Inspiratory Capacity (IC): Sum of
IRV and TV or the maximum
volume of air that can be inhaled
from the end-expiratory tidal
position. (2400-3800ml).
• Expiratory Capacity (EC): TV+ ERV
Lung Capacities (cont.)
• Functional Residual
Capacity (FRC):
– Sum of RV and ERV or the
volume of air in the lungs at
end-expiratory tidal
position.(30-35 ml/kg) (2300-
3300ml).
– Measured with multiple-
breath closed-circuit helium
dilution, multiple-breath
open-circuit nitrogen
washout, or body
plethysmography.
– It can not be measured by
spirometry)
VOLUMES, CAPACITIES AND THEIR
CLINICAL SIGNIFICANCE
1) TIDAL VOLUME (TV):
 VOLUME OF AIR INHALED/EXHALED IN EACH BREATH
DURING QUIET RESPIRATION.
 N – 6-8 ml/kg.
 TV FALLS WITH DECREASE IN COMPLIANCE, DECREASED
VENTILATORY MUSCLE STRENGTH.
2) INSPIRATORY RESERVE VOLUME (IRV):
 MAX. VOL. OF AIR WHICH CAN BE INSPIRED AFTER A
NORMAL TIDAL INSPIRATION i.e. FROM END INSPIRATION PT.
 N- 1900 ml- 3300 ml.
CONTINUED………
3) EXPIRATORY RESERVE VOLUME (ERV):
 MAX. VOLUME OF AIR WHICH CAN BE EXPIRED AFTER A
NORMAL TIDAL EXPIRATION i.e. FROM END EXPIRATION
PT.
 N- 700 ml – 1000 ml
4) INSPIRATORY CAPACITY (IC) :
 MAX. VOL. OF AIR WHICH CAN BE INSPIRED AFTER A
NORMAL TIDAL EXPIRATION.
 IC = IRV + TV
 N-2400 ml – 3800 ml.
CONTINUED………..
4) VITAL CAPACITY: COINED BY JOHN
HUTCHINSON.
MAX. VOL. OF AIR EXPIRED AFTER A MAX.
INSPIRATION .
MEASURED WITH VITALOGRAPH
VC= TV+ERV+IRV
N- 3.1-4.8L. OR 60-70 ml/kg
VC IS COSIDERED ABNORMAL IF ≤ 80% OF
PREDICTED VALUE
FACTORS INFLUENCING VC
• PHYSIOLOGICAL :
 physical dimensions- directly proportional to ht.
 SEX – more in males : large chest size, more
muscle power, more BSA.
 AGE – decreases with increasing age
 STRENGTH OF RESPIRATORY MUSCLES
 POSTURE – decreases in supine position
 PREGNANCY- unchanged or increases by 10% (
increase in AP diameter In pregnancy)
CONTINUED………
• PATHOLOGICAL:
 DISEASE OF RESPIRATORY MUSCLES
ABDOMINAL CONDITION : pain, dis.
FACTORS DECREASING VITAL CAPACITY
1) Alteration in muscle power- d/t drugs, n-m
dis., cerebral tumours.
2) Pulmonary diseases – pneumonia, chronic
bronchitis, asthma, fibrosis, emphysema,
pulmonary edema,.
3) Space occupying lesions in chest- tumours,
pleural/pericardial effusion, kyphoscoliosis
4) Abdominal tumours, ascites.
5) Depression of respiration : opioids
6) Abdominal splinting – abdominal binders,
tight bandages, hip spica.
7)Abdominal pain – decreases by 50% & 75% in
lower & upper abdominal Surgeries
respectively.
8) Posture – by altering pulmonary Blood
volume.
CONTINUED…….
6) TOTAL LUNG CAPACITY :
Maximum volume of air attained in lungs after
maximal inspiration.
N- 4-6 l or 80-100 ml/kg
TLC= VC + RV
7) RESIDUAL VOLUME (RV):
Volume of air remaining in the lungs after
maximal expiration.
N- 1570 – 2100 ml OR 20 – 25 ml/kg.
CONTINUED……
8) FUNCTIONAL RESIDUAL CAPACITY (FRC):
 Volume of air remaining in the lungs after
normal tidal expiration, when there is no airflow.
N- 2.3 -3.3 L OR 30-35 ml/kg.
FRC = RV + ERV
 Decreses under anaesthesia
• with spontaneous Respiration – decreases by
20%
• With paralysis – decreases by 16%
FACTORS AFFECTING FRC
• FRC INCREASES WITH
• Increased height
• Erect position (30% more than in supine)
• Decreased lung recoil (e.g. emphysema)
• FRC DECREASES WITH
• Obesity
• Muscle paralysis (especially in supine)
• Supine position
• Restrictive lung disease (e.g. fibrosis, Pregnancy)
• Anaesthesia
• FRC does NOT change with age.
FUNCTIONS OF FRC
• Oxygen store
• Buffer for maintaining a steady arterial po2
• Partial inflation helps prevent atelectasis
• Minimise the work of breathing
• Minimise pulmonary vascular resistance
• Minimised v/q mismatch
• Keep airway resistance low
Pulmonary Function Tests
• The term encompasses a wide variety of
objective tests to assess lung function
• Provide objective and standardized
measurements for assessing the presence and
severity of respiratory dysfunction.
GOALS
 To predict the presence of pulmonary
dysfunction
To know the functional nature of disease
(obstructive or restrictive. )
To assess the severity of disease
To assess the progression of disease
To assess the response to treatment
To identify patients at increased risk of morbidity
and mortality, undergoing pulmonary resection.
 To wean patient from ventilator in icu.
Medicolegal- to assess lung impairment as a
result of occupational hazard.
Epidemiological surveys- to assess the
hazards to document incidence of disease
To identify patients at perioperative risk of
pulmonary complications
GOALS, CONTINUED……..
BED SIDE PFT
1) Sabrasez breath holding test:
• Ask the patient to take a full but not too deep breath & hold it as
long as possible.
>25 SEC.-NORMAL Cardiopulmonary Reserve (CPR)
15-25 SEC- LIMITED CPR
<15 SEC- VERY POOR CPR (Contraindication for elective surgery)
25- 30 SEC - 3500 ml VC
20 – 25 SEC - 3000 ml VC
15 - 20 SEC - 2500 ml VC
10 - 15 SEC - 2000 ml VC
5 - 10 SEC - 1500 ml VC
BED SIDE PFT
2) Single breath count:
After deep breath, hold it and start counting till the
next breath.
 N- 30-40 COUNT
 Indicates vital capacity
BED SIDE PFT
3) SCHNEIDER’S MATCH BLOWING TEST:
MEASURES Maximum Breathing Capacity.
Ask to blow a match stick from a distance of 6”
(15 cms) with-
 Mouth wide open
 Chin rested/supported
 No purse lipping
 No head movement
 No air movement in the room
 Mouth and match at the same level
BED SIDE PFT
• Can not blow out a match
– MBC < 60 L/min
– FEV1 < 1.6L
• Able to blow out a match
– MBC > 60 L/min
– FEV1 > 1.6L
• MODIFIED MATCH TEST:
DISTANCE MBC
9” >150 L/MIN.
6” >60 L/MIN.
3” > 40 L/MIN.
BED SIDE TEST
4) COUGH TEST: DEEP BREATH F/BY COUGH
 ABILITY TO COUGH
 STRENGTH
 EFFECTIVENESS
INADEQUATE COUGH IF: FVC<20 ML/KG
FEV1 < 15 ML/KG
PEFR < 200 L/MIN.
VC ~ 3 TIMES TV FOR EFFECTIVE COUGH.
A wet productive cough / self propagated paraoxysms
of coughing – patient susceptible for pulmonary
Complication.
BED SIDE TEST
5) FORCED EXPIRATORY TIME:
After deep breath, exhale maximally and
forcefully & keep stethoscope over trachea &
listen.
N FET – 3-5 SECS.
OBS.LUNG DIS. - > 6 SEC
RES. LUNG DIS.- < 3 SEC
BED SIDE PFT
6) WRIGHT PEAK FLOW METER: Measures PEFR (Peak Expiratory Flow
Rate)
N – MALES- 450-700 L/MIN.
FEMALES- 350-500 L/MIN.
<200 L/ MIN. – INADEQUATE COUGH EFFICIENCY.
7) DEBONO WHISTLE BLOWING TEST: MEASURES PEFR.
Patient blows down a wide bore tube at the end of which is a
whistle, on the side is a hole with adjustable knob.
As subject blows → whistle blows, leak hole is gradually increased
till the intensity of whistle disappears.
At the last position at which the whistle can be blown , the PEFR can
be read off the scale.
MEASUREMENT OF TV & MV
8)Wright respirometer : measures tv, mv
• Simple and rapid
• Instrument- compact, light and portable.
• Disadvantage: It under- reads at low flow rates and over- reads at high flow
rates.
• Can be connected to endotracheal tube or face mask
• Prior explanation to patients needed.
• Ideally done in sitting pos.
• MV- instrument record for 1 min. And read directly
• TV-calculated and dividing MV by counting Respiratory Rate.
• USES: 1)BED SIDE PFT
• 2) ICU – WEANIG PTS. FROM Ventilation.
DEBONO’S WHISTLE
BED SIDE PFT
9) MICROSPIROMETERS – MEASURE VC.
10) BED SIDE PULSE OXIMETRY
11) ABG.
CATEGORIZATION OF PFT
1) MECHANICAL VENTILATORY FUNCTIONS OF
LUNG / CHEST WALL:
A) STATIC LUNG VOLUMES & CAPACITIES – VC, IC, IRV,
ERV, RV, FRC.
B) DYNAMIC LUNG VOLUMES –FVC, FEV1, FEF 25-75%,
PEFR, MVV, RESP. MUSCLE STRENGTH
C) VENTILATION TESTS – TV, MV, RR.
CATEGORIZATION OF PFT
2) GAS- EXCHANGE TESTS:
A) Alveolar-arterial po2 gradient
B) Diffusion capacity
C) Gas distribution tests- single breath
N2 test.
- Multiple Breath N2 test
- Helium dilution method.
- Radio Xe scinitigram.
D) ventilation – perfusion tests
A) ABG
B) single breath CO2 elimination test
C) Shunt equation
CATEGORIZATION OF PFT
3) CARDIOPULMONARY INTERACTION:
A) Qualitative tests:
- History , examination
- Abg
- Stair climbing test
B) Quantitative tests
- 6 min. Walk test (gold standard)
www.anaesthesia.co.in
STATIC LUNG VOLUMES AND
CAPACITIES
• SPIROMETRY : CORNERSTONE OF ALL
PFTs.
• John hutchinson – invented spirometer.
• “Spirometry is a medical test that
measures the volume of air an individual
inhales or exhales as a function of time.”
• Measures VC, FVC, FEV1, PEFR.
• CAN’T MEASURE – FRC, RV, TLC.
PREREQUISITIES
• Prior explanation to the patient
• Not to smoke /inhale bronchodilators 6 hrs
prior or oral bronchodilators 12hrs prior.
• Remove any tight clothings/ waist belt/
dentures
• Pt. Seated comfortably
If obese, child < 12 yrs- standing
PREREQUISITES
• Nose clip to close nostrils.
• Exp. Effort shld last ≥ 4 secs.
• Should not be interfered by coughing, glottic
closure, mechanical obstruction.
• 3 acceptable tracings taken & largest value is
used.
SPIROMETER
• Double walled cylinder with water to maintain
water tight seal
• Inverted bell attached to pulley which carries
a counterweight and pen – moves up and
down as volume of bell changes
• BREATHING ASSEMBLY i.E. Unidirectional
breathing valves with mouth piece.
Flow-Volume Curves and Spirograms
• Two ways to record results of FVC maneuver:
– Flow-volume curve---flow meter measures flow
rate in L/s upon exhalation; flow plotted as
function of volume
– Classic spirogram---volume as a function of time
Normal Flow-Volume Curve and
Spirogram
www.anaesthesia.co.in
Spirometry Interpretation: So what
constitutes normal?
• Normal values vary and depend on:
– Height
– Age
– Gender
– Ethnicity
Acceptable and Unacceptable
Spirograms (from ATS, 1994)
www.anaesthesia.co.in
Measurements Obtained from the FVC
Curve
• FEV1---the volume exhaled during the first second of the FVC
maneuver
• FEF 25-75%---the mean expiratory flow during the middle half
of the FVC maneuver; reflects flow through the small (<2 mm
in diameter) airways
• FEV1/FVC---the ratio of FEV1 to FVC X 100 (expressed as a
percent); an important value because a reduction of this ratio
from expected values is specific for obstructive rather than
restrictive diseases
Spirometry Interpretation: Obstructive
vs. Restrictive Defect
• Obstructive Disorders
– Characterized by a limitation
of expiratory airflow so that
airways cannot empty as
rapidly compared to normal
(such as through narrowed
airways from bronchospasm,
inflammation, etc.)
Examples:
– Asthma
– Emphysema
– Cystic Fibrosis
• Restrictive Disorders
– Characterized by reduced
lung volumes/decreased lung
compliance
Examples:
– Interstitial Fibrosis
– Scoliosis
– Obesity
– Lung Resection
– Neuromuscular diseases
– Cystic Fibrosis
Normal vs. Obstructive vs. Restrictive
(Hyatt,
2003)
Spirometry Interpretation: Obstructive
vs. Restrictive Defect
• Obstructive Disorders
– FVC nl or↓
– FEV1 ↓
– FEF25-75% ↓
– FEV1/FVC ↓
– TLC nl or ↑
• Restrictive Disorders
– FVC ↓
– FEV1 ↓
– FEF 25-75% nl to ↓
– FEV1/FVC nl to ↑
– TLC ↓
Spirometry Interpretation: What do the
numbers mean?
• FVC
• Interpretation of %
predicted:
– 80-120% Normal
– 70-79% Mild reduction
– 50%-69% Moderate reduction
– <50% Severe reduction
FEV1
Interpretation of % predicted:
– >75% Normal
– 60%-75% Mild obstruction
– 50-59% Moderate obstruction
– <49% Severe obstruction
Spirometry Interpretation: What do the
numbers mean?
• FEF 25-75%
• Interpretation of %
predicted:
– >79% Normal
– 60-79% Mild
obstruction
– 40-59% Moderate
obstruction
– <40% Severe obstruction
• FEV1/FVC
• Interpretation of
absolute value:
– 80 or higher
Normal
– 79 or lower
Abnormal
What about lung volumes and obstructive
and restrictive disease?
MEASUREMENTS OF VOLUMES
• TLC, RV, FRC – MEASURED USING
Nitrogen washout method
Inert gas (helium) dilution method
Total body plethysmography
CONTINUED………..
1) HELIUM DILUTION METHOD:
Patient breathes in and out of a spirometer filled with 10%
helium and 90% o2, till conc. In spirometer and lung
becomes same (equilibirium).
As no helium is lost; (as it is insoluble in blood)
C1 X V1 = C2 ( V1 + V2)
V2 = V1 ( C1 – C2)
C2
V1= VOL. OF SPIROMETER
V2= FRC
C1= Conc.of He in the spirometer before equilibrium
C2 = Conc, of He in the spirometer after equilibrium
CONTINUED………
2) TOTAL BODY PLETHYSMOGRAPHY:
Subject sits in an air tight box. At the end of normal exhalation – shuttle of
mouthpiece closed and pt. is asked to make resp. efforts. As subject
inhales – expands gas volume in the lung so lung vol. increases and box
pressure rises and box vol. decreases.
BOYLE’S LAW:
PV = CONSTANT (at constant temp.)
For Box – p1v1 = p2 (v1- ∆v)
For Subject – p3 x v2 =p4 (v2 - ∆v)
P1- initial box pr. P2- final box pr.
V1- initial box vol. ∆ v- change in box vol.
P3- initial mouth pr., p4- final mouth pr.
V2- FRC
CONTINUED………
DIFFERENCE BETWEEN THE TWO METHODS:
• In healthy people there is very little difference.
• Gas dilution technique measures only the
communicating gas volume.
• Thus,
• Gas trapped behind closed airways
• Gas in pneumothorax
• => are not measured by gas dilution technique,
but measured by body plethysmograph
CONTINUED………
3) N2 WASH OUT METHOD:
• Following a maximal expiration (RV) or normal
expiration (FRC), Pt. inspires 100% O2 and
then expires it into spirometer ( free of N2) →
over next few minutes (usually 6-7 min.), till
all the N2 is washed out of the lungs. N2
conc. of spirometer is calculated followed by
total vol.of AIR exhaled. As air has 80% N2 →
so actual FRC/RV is calculated.
MEASUREMENT OF DYNAMIC LUNG
VOLUMES
• TIMED EXPIRED SPIROGRAMS
FEF25–75% = forced
expiratory flow during
expiration of 25 to 75% of
the FVC; FEV1 = forced
expiratory volume in the
first second of forced vital
capacity maneuver; FVC =
forced vital capacity (the
maximum amount of air
forcibly expired after
maximum inspiration).
FORCED VITAL CAPACITY (FVC)
Max vol. Of air which can be expired out as forcefully and
rapidly as possible, following a maximal inspiration to
TLC.
 Exhaled volume is recorded with respect to time.
 Indirectly reflects flow resistance property of airways.
 Normal healthy subjects have VC = FVC.
 Prior instruction to patients, practice attempts as it
needs patient cooperation and effect.
 Exhalation should take at least 4 sec and should not be
interrupted by cough, glottic closure or mechanical
obstruction.
FORCED VITAL CAPACITY IN 1 SEC.
(FEV1)
Forced expired vol. In 1 sec during fvc
maneuver.
Expressed as an absolute value or % of fvc.
N- FEV1 (1 SEC)- 75-85% OF FVC
 FEV2 (2 SEC)- 94% OF FVC
 FEV3 (3 SEC)- 97% OF FVC
CONTINUED……
CLINICAL RANGE (FEV1)
• 3 - 4.5 L
• 1.5 – 2.5 L
• <1 L
• 0.8 L
• 0.5 L
PATIENT GROUP
• NORMAL ADULT
• MILD – MOD.OBSTRUCTION
• HANDICAPPED
• DISABILITY
• SEVERE EMPHYSEMA
CONTINUED……
FEV1 – Decreased in both obstructive &
restrictive lung disorders.
FEV1/FVC – Reduced in obstructive disorders.
NORMAL VALUE IS 75 – 85 % (FEV1/FVC)
< 70% OF PREDICTED VALUE – MILD OBST.
< 60% OF PREDICTED VALUE – MODERATE OBST.
< 50% OF PREDICTED VALUE – SEVERE OBST.
CONTINUED……
DISEASE STATES FVC FEV1 FEV1/FVC
1) OBSTRUCTIVE NORMAL ↓ ↓
2) STIFF LUNGS ↓ ↓ NORMAL
3 ) RESP. MUSCLE
WEAKNESS
↓ ↓ NORMAL
PEAK EXPIRATORY FLOW RATE (PEFR)
- It is the max. Flow rate during fvc maneuver in the initial 0.1
sec.
-PEFR DETERMINED BY : 1) Function of caliber of airways
2) Expiratory muscle strength
3) Pt’s coordination & effort
- Estimated by 1) drawing a tangent to steepest part of FVC
spirogram (error prone)
2) average flow during the litre of gas expired after
initial 200 ml during fvc maneuver.
- .
FORCED MID-EXPIRATORY FLOW RATE
(FEF25%-75%):
• Maximum Mid expiratory Flow rate
• Max. Flow rate during the mid-expiratory part of FVC maneuver.
• Effort independent
• Misnomer, as FEF25-75% decreased by
1) marked reduction in exp. Effort
2)submaximal inspiration b4 maneuver → ↓FVC → ↓ FEF25-
75%
• It may decrease with truly max. Effort as compared to slightly
submaximal effort as dynamic airway compression occurs with
maximal effort.
• N value – 4.5-5 l/sec. Or 300 l/min.
• Upto 2l/sec- acceptable.
• CLINICAL SIGNIFICANCE: SENSITIVE & IST INDICATOR OF
OBSTRUCTION OF SMALL DISTAL AIRWAYS
MAXIMUM BREATHING CAPACITY:
(MBC/MVV)
• MAX. VOLUNTARY VENTILATION
 Largest volume that can be breathed per minute by voluntary
effort , as hard & as fast as possible.
 N – 150-175 l/min.
 Estimate of max. Ventilation available to meet increased
physiological demand.
 Measured for 12 secs – extrapolated for 1 min.
 MVV = FEV1 X 35
CONTINUED…….
• Discrepancy b/w FEV1 and MVV means inconsistent /
submaximal inspiratory effort
• MBC/MVV altered by- airway resistance
- Elastic property
-Muscle strength
- Learning
- Coordination
- Motivation
RESPIRATORY MUSCLE STRENGTH
Evaluated by measuring max. Static resp. Pressure with
anaeroid gauge
• Pressures are generated against occluded airway
during a max. Forced insp/exp. Effort
MAX STATIC INSP. PRESSURE: (PIMAX)-
• Measured when inspiratory muscles are at their
optimal length i.e. at RV
• PI MAX = -125 CM H2O
• CLINICAL SIGNIFICANCE:
 IF PI MAX< 25 CM H2O – Inability to take deep breath.
CONTINUED…….
• MAX. STATIC EXPIRATORY PRESSURE (PEMAX):
 Measured after full inspiration to TLC
 N VALUE OF PEMAX IS =200 CM H20
 PEMAX < +40 CM H20 – Impaired cough ability
 Particularly useful in pts with NM Disorders during
weaning
MEASUREMENT OF AIRWAY
RESISTANCE
1) Raw- Body plethysmography
2) Forced expiratory maneuvers:
 Peak expiratory flow (PEF)
FEV1
3) Response to bronchodialtors (FEV1)
Spirometry Pre and Post Bronchodilator
• Obtain a flow-volume loop.
• Administer a bronchodilator.
• Obtain the flow-volume loop again a minimum of 15
minutes after administration of the bronchodilator.
• Calculate percent change (FEV1 most commonly
used---so % change FEV 1= [(FEV1 Post-FEV1
Pre)/FEV1 Pre] X 100).
• Reversibility is with 12% or greater change.
FLOW VOLUME LOOPS
• Do FVC maneuver and then inhale as rapidly
and as much as able.
• This makes an inspiratory curve.
• The expiratory and inspiratory flow volume
curves put together make a flow volume loop.
Flow-Volume Loops
(Rudolph and
Rudolph, 2003)
How is a flow-volume loop helpful?
• Helpful in evaluation of air flow limitation on inspiration and
expiration
• In addition to obstructive and restrictive patterns, flow-
volume loops can show provide information on upper airway
obstruction:
– Fixed obstruction: constant airflow limitation on inspiration and
expiration—such as in tumor, tracheal stenosis
– Variable extrathoracic obstruction: limitation of inspiratory flow,
flattened inspiratory loop—such as in vocal cord dysfunction
– Variable intrathoracic obstruction: flattening of expiratory limb; as in
malignancy or tracheomalacia
TESTS FOR GAS EXCHANGE FUNCTION
1) ALVEOLAR-ARTERIAL O2 TENSION GRADIENT:
 Sensitive indicator of detecting regional V/Q inequality
 N value in young adult at room air = 8 mmhg to upto
25 mmhg in 8th decade (d/t decrease in PaO2)
 AbN high values at room air is seen in asymptomatic
smokers & chr. Bronchitis (min. symptoms)
PAO2 = PIO2 – PaCo2
R
CONTINUED……..
2) DYSPNEA DIFFENRENTIATION INDEX (DDI):
- To d/f dyspnea due to resp/ cardiac d’s
DDI = PEFR x PaCO2
1000
- DDI- Lower in resp. pathology
CONTINUED……
3) DIFFUSING CAPACITY OF LUNG: defined as the
rate at which gas enters into bld. divided by its
driving pr.
DRIVING PR: gradient b/w alveoli & end capillary
tensions.
Fick’s law of diffusion : Vgas = A x D x (P1-P2)
T
D= diffusion coeff= solubility
√MW
CONTINUED…….
• DL IS MEASURED BY USING CO, COZ:
A) High affinity for Hb which is approx. 200
times that of O2 , so does not rapidly build
up in plasma
B) Under N condition it has low bld conc ≈ 0
C) Therefore, pulm conc.≈0
SINGLE BREATH TEST USING CO
• Pt inspires a dilute mixture of CO and hold the
breath for 10 secs.
• CO taken up is determined by infrared
analysis:
• DlCO = CO ml/min/mmhg
• PACO – PcCO
• N range 20- 30 ml/min./mmhg.
• DLO2 = DLCO x 1.23
DLCO decreases in-
• Emphysema, lung resection, pul. Embolism, anaemia
• Pulmonary fibrosis, sarcoidosis- increased thickness
• DLCO increases in:
(Cond. Which increase pulm, bld flow)
 Supine position
 Exercise
 Obesity
 L-R shunt
TESTS FOR CARDIOPLULMONARY
INTERACTIONS
• Reflects gas exchange, ventilation, tissue O2,
CO.
• QUALITATIVE- history, exam, ABG, stair
climbing test
• QUANTITATIVE- 6 minute walk test
CONTINUED…….
• 1) STAIR CLIMBING TEST:
• If able to climb 3 flights of stairs without stopping/dypnoea at
his/her own pace- ↓ed morbidity & mortality
• If not able to climb 2 flights – high risk
• 2) 6 MINUTE WALK TEST:
- Gold standard
- C.P. reserve is measured by estimating max. O2 uptake during
exercise
- Modified if pt. can’t walk – bicycle/ arm exercises
- If pt. is able to walk for >2000 feet during 6 min pd,
- VO2 max > 15 ml/kg/min
- If 1080 feet in 1 min : VO2 of 12ml/kg/min
- Simultaneously oximetry is done & if Spo2 falls >4%- high risk
THANKYOU

Contenu connexe

Tendances

Recruitment maneuvers in ards
Recruitment maneuvers in ardsRecruitment maneuvers in ards
Recruitment maneuvers in ardsAnusha Jahagirdar
 
Interpretation OF PFT
Interpretation OF PFT		Interpretation OF PFT
Interpretation OF PFT Khalid
 
Spirometry Interpretation
Spirometry Interpretation Spirometry Interpretation
Spirometry Interpretation Ashraf ElAdawy
 
pulmonary function test
pulmonary function test pulmonary function test
pulmonary function test imsurgeon
 
Pulmonary function testing (spirometry )
Pulmonary function testing (spirometry ) Pulmonary function testing (spirometry )
Pulmonary function testing (spirometry ) Dr Emad efat
 
Obstructive and restrictive of lung disease
Obstructive and restrictive of lung diseaseObstructive and restrictive of lung disease
Obstructive and restrictive of lung diseaseHAMAD DHUHAYR
 
Pulmonary function test
Pulmonary function testPulmonary function test
Pulmonary function testravindrajha10
 
Respiratory function and importance to anesthesia final
Respiratory function and importance to anesthesia  finalRespiratory function and importance to anesthesia  final
Respiratory function and importance to anesthesia finalDrUday Pratap Singh
 
Introduction to Pulmonary function test
Introduction to Pulmonary function testIntroduction to Pulmonary function test
Introduction to Pulmonary function testPrince Maurya
 
Interpretation of CPET
Interpretation of CPETInterpretation of CPET
Interpretation of CPETSamiaa Sadek
 
Pulmonary Function Tests
Pulmonary Function TestsPulmonary Function Tests
Pulmonary Function TestsAntara Banerji
 
Recruitment Maneuvers in ARDS Dr Chennamchetty Vijay Kumar
Recruitment  Maneuvers in ARDS Dr Chennamchetty Vijay KumarRecruitment  Maneuvers in ARDS Dr Chennamchetty Vijay Kumar
Recruitment Maneuvers in ARDS Dr Chennamchetty Vijay KumarVizae Kumar Chennam
 
Pulmonary function test
Pulmonary function test Pulmonary function test
Pulmonary function test IMRAN MEHDI
 
PFT and Interstitial lung diseases
PFT and Interstitial lung diseasesPFT and Interstitial lung diseases
PFT and Interstitial lung diseasesChakradhar Reddy
 

Tendances (20)

Spirometry
SpirometrySpirometry
Spirometry
 
Recruitment maneuvers in ards
Recruitment maneuvers in ardsRecruitment maneuvers in ards
Recruitment maneuvers in ards
 
Interpretation OF PFT
Interpretation OF PFT		Interpretation OF PFT
Interpretation OF PFT
 
DLCO
DLCO DLCO
DLCO
 
Spirometry Interpretation
Spirometry Interpretation Spirometry Interpretation
Spirometry Interpretation
 
pulmonary function test
pulmonary function test pulmonary function test
pulmonary function test
 
Pulmonary function testing (spirometry )
Pulmonary function testing (spirometry ) Pulmonary function testing (spirometry )
Pulmonary function testing (spirometry )
 
Pulmonary function test, bronchial challenge test, and FeNO.pdf
Pulmonary function test, bronchial challenge test, and FeNO.pdfPulmonary function test, bronchial challenge test, and FeNO.pdf
Pulmonary function test, bronchial challenge test, and FeNO.pdf
 
Obstructive and restrictive of lung disease
Obstructive and restrictive of lung diseaseObstructive and restrictive of lung disease
Obstructive and restrictive of lung disease
 
Pulmonary function test
Pulmonary function testPulmonary function test
Pulmonary function test
 
Respiratory function and importance to anesthesia final
Respiratory function and importance to anesthesia  finalRespiratory function and importance to anesthesia  final
Respiratory function and importance to anesthesia final
 
Introduction to Pulmonary function test
Introduction to Pulmonary function testIntroduction to Pulmonary function test
Introduction to Pulmonary function test
 
Interpretation of CPET
Interpretation of CPETInterpretation of CPET
Interpretation of CPET
 
Spirometry
SpirometrySpirometry
Spirometry
 
Asthma biomarkers: FENO
Asthma biomarkers: FENOAsthma biomarkers: FENO
Asthma biomarkers: FENO
 
14. pulmonary-function-tests
14. pulmonary-function-tests14. pulmonary-function-tests
14. pulmonary-function-tests
 
Pulmonary Function Tests
Pulmonary Function TestsPulmonary Function Tests
Pulmonary Function Tests
 
Recruitment Maneuvers in ARDS Dr Chennamchetty Vijay Kumar
Recruitment  Maneuvers in ARDS Dr Chennamchetty Vijay KumarRecruitment  Maneuvers in ARDS Dr Chennamchetty Vijay Kumar
Recruitment Maneuvers in ARDS Dr Chennamchetty Vijay Kumar
 
Pulmonary function test
Pulmonary function test Pulmonary function test
Pulmonary function test
 
PFT and Interstitial lung diseases
PFT and Interstitial lung diseasesPFT and Interstitial lung diseases
PFT and Interstitial lung diseases
 

En vedette

Simple Interpretation of Pulmonary Function tests
Simple Interpretation of Pulmonary Function testsSimple Interpretation of Pulmonary Function tests
Simple Interpretation of Pulmonary Function testsGamal Agmy
 
The mantoux test
The mantoux testThe mantoux test
The mantoux testAzizah Mh
 
Nurses role in arterial puncture and abg analysis
Nurses role in arterial puncture and abg analysisNurses role in arterial puncture and abg analysis
Nurses role in arterial puncture and abg analysisStephy Stanly
 
Basics In Arterial Blood Gas Interpretation
Basics In Arterial Blood Gas InterpretationBasics In Arterial Blood Gas Interpretation
Basics In Arterial Blood Gas Interpretationgueste36950a
 
Arterial Blood Bas (ABG) Procedure and Interpretation
Arterial Blood Bas (ABG) Procedure and InterpretationArterial Blood Bas (ABG) Procedure and Interpretation
Arterial Blood Bas (ABG) Procedure and InterpretationLouie Ray
 
Basic interpretation of cxr
Basic interpretation of cxrBasic interpretation of cxr
Basic interpretation of cxrKochi Chia
 
Bronchoscopy ppt
Bronchoscopy pptBronchoscopy ppt
Bronchoscopy pptmissmarimo
 
Pulmonary Function Test.ppt
Pulmonary Function Test.pptPulmonary Function Test.ppt
Pulmonary Function Test.pptShama
 

En vedette (20)

Allergy skin test
Allergy skin testAllergy skin test
Allergy skin test
 
Simple Interpretation of Pulmonary Function tests
Simple Interpretation of Pulmonary Function testsSimple Interpretation of Pulmonary Function tests
Simple Interpretation of Pulmonary Function tests
 
The mantoux test
The mantoux testThe mantoux test
The mantoux test
 
Spirometry Basics
Spirometry BasicsSpirometry Basics
Spirometry Basics
 
Blood Gas Interpretation
Blood Gas InterpretationBlood Gas Interpretation
Blood Gas Interpretation
 
Abg skill station
Abg skill stationAbg skill station
Abg skill station
 
Abg in clinical practice
Abg in clinical practiceAbg in clinical practice
Abg in clinical practice
 
ABG by DJ
ABG by DJABG by DJ
ABG by DJ
 
Nurses role in arterial puncture and abg analysis
Nurses role in arterial puncture and abg analysisNurses role in arterial puncture and abg analysis
Nurses role in arterial puncture and abg analysis
 
Acid base determination
Acid base determinationAcid base determination
Acid base determination
 
Basics In Arterial Blood Gas Interpretation
Basics In Arterial Blood Gas InterpretationBasics In Arterial Blood Gas Interpretation
Basics In Arterial Blood Gas Interpretation
 
Abg
AbgAbg
Abg
 
Arterial Blood Bas (ABG) Procedure and Interpretation
Arterial Blood Bas (ABG) Procedure and InterpretationArterial Blood Bas (ABG) Procedure and Interpretation
Arterial Blood Bas (ABG) Procedure and Interpretation
 
Basic interpretation of cxr
Basic interpretation of cxrBasic interpretation of cxr
Basic interpretation of cxr
 
ABG by a taecher
ABG by a taecherABG by a taecher
ABG by a taecher
 
Bronchoscopy ppt
Bronchoscopy pptBronchoscopy ppt
Bronchoscopy ppt
 
Bronchoscopy
BronchoscopyBronchoscopy
Bronchoscopy
 
Pulmonary Function Test.ppt
Pulmonary Function Test.pptPulmonary Function Test.ppt
Pulmonary Function Test.ppt
 
X rays
X raysX rays
X rays
 
ABG Interpretation
ABG InterpretationABG Interpretation
ABG Interpretation
 

Similaire à 14. pulmonary-function-tests

Similaire à 14. pulmonary-function-tests (20)

Pulmonary-Function-Tests and it's importance ppt
Pulmonary-Function-Tests and it's importance pptPulmonary-Function-Tests and it's importance ppt
Pulmonary-Function-Tests and it's importance ppt
 
Bedside respiratory assessment & spirometry
Bedside respiratory assessment & spirometryBedside respiratory assessment & spirometry
Bedside respiratory assessment & spirometry
 
Pft 10.12.14
Pft 10.12.14Pft 10.12.14
Pft 10.12.14
 
Pulmonary function test
Pulmonary function testPulmonary function test
Pulmonary function test
 
Lvcp
LvcpLvcp
Lvcp
 
Pulmonary function
Pulmonary functionPulmonary function
Pulmonary function
 
PULMONARY FUNCTION TESTS
PULMONARY FUNCTION TESTSPULMONARY FUNCTION TESTS
PULMONARY FUNCTION TESTS
 
PFT.pdf
PFT.pdfPFT.pdf
PFT.pdf
 
PFT
PFTPFT
PFT
 
pulmonary function tests
pulmonary function testspulmonary function tests
pulmonary function tests
 
Pulmonary function tests
Pulmonary function testsPulmonary function tests
Pulmonary function tests
 
spirometry functional lung test
spirometry functional lung test spirometry functional lung test
spirometry functional lung test
 
lung volumes new v.pptx
lung volumes new v.pptxlung volumes new v.pptx
lung volumes new v.pptx
 
Spirometry
SpirometrySpirometry
Spirometry
 
pulmonary Function Test
pulmonary Function Testpulmonary Function Test
pulmonary Function Test
 
PFT 3rd year FDPS.pptx
PFT 3rd year FDPS.pptxPFT 3rd year FDPS.pptx
PFT 3rd year FDPS.pptx
 
spirometry.pptx
spirometry.pptxspirometry.pptx
spirometry.pptx
 
lung function tests.pptx
lung function tests.pptxlung function tests.pptx
lung function tests.pptx
 
LUNG FUNCTION TEST.pptx
LUNG FUNCTION TEST.pptxLUNG FUNCTION TEST.pptx
LUNG FUNCTION TEST.pptx
 
spirometry .pptx
spirometry .pptxspirometry .pptx
spirometry .pptx
 

Dernier

Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)MohamadAlhes
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamAkebom Gebremichael
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfMyThaoAiDoan
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...Divya Kanojiya
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 

Dernier (20)

Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 

14. pulmonary-function-tests

  • 2. Lung Volumes and Capacities PFT tracings have:  Four Lung volumes: tidal volume, inspiratory reserve volume, expiratory reserve volume, and residual volume  Five capacities:, inspiratory capacity, expiratory capacity, vital capacity, functional residual capacity, and total lung capacity Addition of 2 or more volumes comprise a capacity.
  • 3. Lung Volumes • Tidal Volume (TV): volume of air inhaled or exhaled with each breath during quiet breathing (6- 8 ml/kg) • Inspiratory Reserve Volume (IRV): maximum volume of air inhaled from the end-inspiratory tidal position.(1900-3300ml) • Expiratory Reserve Volume (ERV): maximum volume of air that can be exhaled from resting end-expiratory tidal position.( 700-1000ml).
  • 4. Lung Volumes • Residual Volume (RV): – Volume of air remaining in lungs after maximium exhalation (20-25 ml/kg) (1700-2100ml) – Indirectly measured (FRC-ERV) – It can not be measured by spirometry
  • 5. Lung Capacities • Total Lung Capacity (TLC): Sum of all volume compartments or volume of air in lungs after maximum inspiration (4-6 L) • Vital Capacity (VC): TLC minus RV or maximum volume of air exhaled from maximal inspiratory level. (60-70 ml/kg) (3100-4800ml) • Inspiratory Capacity (IC): Sum of IRV and TV or the maximum volume of air that can be inhaled from the end-expiratory tidal position. (2400-3800ml). • Expiratory Capacity (EC): TV+ ERV
  • 6. Lung Capacities (cont.) • Functional Residual Capacity (FRC): – Sum of RV and ERV or the volume of air in the lungs at end-expiratory tidal position.(30-35 ml/kg) (2300- 3300ml). – Measured with multiple- breath closed-circuit helium dilution, multiple-breath open-circuit nitrogen washout, or body plethysmography. – It can not be measured by spirometry)
  • 7. VOLUMES, CAPACITIES AND THEIR CLINICAL SIGNIFICANCE 1) TIDAL VOLUME (TV):  VOLUME OF AIR INHALED/EXHALED IN EACH BREATH DURING QUIET RESPIRATION.  N – 6-8 ml/kg.  TV FALLS WITH DECREASE IN COMPLIANCE, DECREASED VENTILATORY MUSCLE STRENGTH. 2) INSPIRATORY RESERVE VOLUME (IRV):  MAX. VOL. OF AIR WHICH CAN BE INSPIRED AFTER A NORMAL TIDAL INSPIRATION i.e. FROM END INSPIRATION PT.  N- 1900 ml- 3300 ml.
  • 8. CONTINUED……… 3) EXPIRATORY RESERVE VOLUME (ERV):  MAX. VOLUME OF AIR WHICH CAN BE EXPIRED AFTER A NORMAL TIDAL EXPIRATION i.e. FROM END EXPIRATION PT.  N- 700 ml – 1000 ml 4) INSPIRATORY CAPACITY (IC) :  MAX. VOL. OF AIR WHICH CAN BE INSPIRED AFTER A NORMAL TIDAL EXPIRATION.  IC = IRV + TV  N-2400 ml – 3800 ml.
  • 9. CONTINUED……….. 4) VITAL CAPACITY: COINED BY JOHN HUTCHINSON. MAX. VOL. OF AIR EXPIRED AFTER A MAX. INSPIRATION . MEASURED WITH VITALOGRAPH VC= TV+ERV+IRV N- 3.1-4.8L. OR 60-70 ml/kg VC IS COSIDERED ABNORMAL IF ≤ 80% OF PREDICTED VALUE
  • 10. FACTORS INFLUENCING VC • PHYSIOLOGICAL :  physical dimensions- directly proportional to ht.  SEX – more in males : large chest size, more muscle power, more BSA.  AGE – decreases with increasing age  STRENGTH OF RESPIRATORY MUSCLES  POSTURE – decreases in supine position  PREGNANCY- unchanged or increases by 10% ( increase in AP diameter In pregnancy)
  • 11. CONTINUED……… • PATHOLOGICAL:  DISEASE OF RESPIRATORY MUSCLES ABDOMINAL CONDITION : pain, dis.
  • 12. FACTORS DECREASING VITAL CAPACITY 1) Alteration in muscle power- d/t drugs, n-m dis., cerebral tumours. 2) Pulmonary diseases – pneumonia, chronic bronchitis, asthma, fibrosis, emphysema, pulmonary edema,. 3) Space occupying lesions in chest- tumours, pleural/pericardial effusion, kyphoscoliosis 4) Abdominal tumours, ascites.
  • 13. 5) Depression of respiration : opioids 6) Abdominal splinting – abdominal binders, tight bandages, hip spica. 7)Abdominal pain – decreases by 50% & 75% in lower & upper abdominal Surgeries respectively. 8) Posture – by altering pulmonary Blood volume.
  • 14. CONTINUED……. 6) TOTAL LUNG CAPACITY : Maximum volume of air attained in lungs after maximal inspiration. N- 4-6 l or 80-100 ml/kg TLC= VC + RV 7) RESIDUAL VOLUME (RV): Volume of air remaining in the lungs after maximal expiration. N- 1570 – 2100 ml OR 20 – 25 ml/kg.
  • 15. CONTINUED…… 8) FUNCTIONAL RESIDUAL CAPACITY (FRC):  Volume of air remaining in the lungs after normal tidal expiration, when there is no airflow. N- 2.3 -3.3 L OR 30-35 ml/kg. FRC = RV + ERV  Decreses under anaesthesia • with spontaneous Respiration – decreases by 20% • With paralysis – decreases by 16%
  • 16. FACTORS AFFECTING FRC • FRC INCREASES WITH • Increased height • Erect position (30% more than in supine) • Decreased lung recoil (e.g. emphysema) • FRC DECREASES WITH • Obesity • Muscle paralysis (especially in supine) • Supine position • Restrictive lung disease (e.g. fibrosis, Pregnancy) • Anaesthesia • FRC does NOT change with age.
  • 17. FUNCTIONS OF FRC • Oxygen store • Buffer for maintaining a steady arterial po2 • Partial inflation helps prevent atelectasis • Minimise the work of breathing • Minimise pulmonary vascular resistance • Minimised v/q mismatch • Keep airway resistance low
  • 18. Pulmonary Function Tests • The term encompasses a wide variety of objective tests to assess lung function • Provide objective and standardized measurements for assessing the presence and severity of respiratory dysfunction.
  • 19. GOALS  To predict the presence of pulmonary dysfunction To know the functional nature of disease (obstructive or restrictive. ) To assess the severity of disease To assess the progression of disease To assess the response to treatment To identify patients at increased risk of morbidity and mortality, undergoing pulmonary resection.
  • 20.  To wean patient from ventilator in icu. Medicolegal- to assess lung impairment as a result of occupational hazard. Epidemiological surveys- to assess the hazards to document incidence of disease To identify patients at perioperative risk of pulmonary complications GOALS, CONTINUED……..
  • 21. BED SIDE PFT 1) Sabrasez breath holding test: • Ask the patient to take a full but not too deep breath & hold it as long as possible. >25 SEC.-NORMAL Cardiopulmonary Reserve (CPR) 15-25 SEC- LIMITED CPR <15 SEC- VERY POOR CPR (Contraindication for elective surgery) 25- 30 SEC - 3500 ml VC 20 – 25 SEC - 3000 ml VC 15 - 20 SEC - 2500 ml VC 10 - 15 SEC - 2000 ml VC 5 - 10 SEC - 1500 ml VC
  • 22. BED SIDE PFT 2) Single breath count: After deep breath, hold it and start counting till the next breath.  N- 30-40 COUNT  Indicates vital capacity
  • 23. BED SIDE PFT 3) SCHNEIDER’S MATCH BLOWING TEST: MEASURES Maximum Breathing Capacity. Ask to blow a match stick from a distance of 6” (15 cms) with-  Mouth wide open  Chin rested/supported  No purse lipping  No head movement  No air movement in the room  Mouth and match at the same level
  • 24. BED SIDE PFT • Can not blow out a match – MBC < 60 L/min – FEV1 < 1.6L • Able to blow out a match – MBC > 60 L/min – FEV1 > 1.6L • MODIFIED MATCH TEST: DISTANCE MBC 9” >150 L/MIN. 6” >60 L/MIN. 3” > 40 L/MIN.
  • 25. BED SIDE TEST 4) COUGH TEST: DEEP BREATH F/BY COUGH  ABILITY TO COUGH  STRENGTH  EFFECTIVENESS INADEQUATE COUGH IF: FVC<20 ML/KG FEV1 < 15 ML/KG PEFR < 200 L/MIN. VC ~ 3 TIMES TV FOR EFFECTIVE COUGH. A wet productive cough / self propagated paraoxysms of coughing – patient susceptible for pulmonary Complication.
  • 26. BED SIDE TEST 5) FORCED EXPIRATORY TIME: After deep breath, exhale maximally and forcefully & keep stethoscope over trachea & listen. N FET – 3-5 SECS. OBS.LUNG DIS. - > 6 SEC RES. LUNG DIS.- < 3 SEC
  • 27. BED SIDE PFT 6) WRIGHT PEAK FLOW METER: Measures PEFR (Peak Expiratory Flow Rate) N – MALES- 450-700 L/MIN. FEMALES- 350-500 L/MIN. <200 L/ MIN. – INADEQUATE COUGH EFFICIENCY. 7) DEBONO WHISTLE BLOWING TEST: MEASURES PEFR. Patient blows down a wide bore tube at the end of which is a whistle, on the side is a hole with adjustable knob. As subject blows → whistle blows, leak hole is gradually increased till the intensity of whistle disappears. At the last position at which the whistle can be blown , the PEFR can be read off the scale.
  • 28. MEASUREMENT OF TV & MV 8)Wright respirometer : measures tv, mv • Simple and rapid • Instrument- compact, light and portable. • Disadvantage: It under- reads at low flow rates and over- reads at high flow rates. • Can be connected to endotracheal tube or face mask • Prior explanation to patients needed. • Ideally done in sitting pos. • MV- instrument record for 1 min. And read directly • TV-calculated and dividing MV by counting Respiratory Rate. • USES: 1)BED SIDE PFT • 2) ICU – WEANIG PTS. FROM Ventilation.
  • 30. BED SIDE PFT 9) MICROSPIROMETERS – MEASURE VC. 10) BED SIDE PULSE OXIMETRY 11) ABG.
  • 31. CATEGORIZATION OF PFT 1) MECHANICAL VENTILATORY FUNCTIONS OF LUNG / CHEST WALL: A) STATIC LUNG VOLUMES & CAPACITIES – VC, IC, IRV, ERV, RV, FRC. B) DYNAMIC LUNG VOLUMES –FVC, FEV1, FEF 25-75%, PEFR, MVV, RESP. MUSCLE STRENGTH C) VENTILATION TESTS – TV, MV, RR.
  • 32. CATEGORIZATION OF PFT 2) GAS- EXCHANGE TESTS: A) Alveolar-arterial po2 gradient B) Diffusion capacity C) Gas distribution tests- single breath N2 test. - Multiple Breath N2 test - Helium dilution method. - Radio Xe scinitigram. D) ventilation – perfusion tests A) ABG B) single breath CO2 elimination test C) Shunt equation
  • 33. CATEGORIZATION OF PFT 3) CARDIOPULMONARY INTERACTION: A) Qualitative tests: - History , examination - Abg - Stair climbing test B) Quantitative tests - 6 min. Walk test (gold standard) www.anaesthesia.co.in
  • 34. STATIC LUNG VOLUMES AND CAPACITIES • SPIROMETRY : CORNERSTONE OF ALL PFTs. • John hutchinson – invented spirometer. • “Spirometry is a medical test that measures the volume of air an individual inhales or exhales as a function of time.” • Measures VC, FVC, FEV1, PEFR. • CAN’T MEASURE – FRC, RV, TLC.
  • 35. PREREQUISITIES • Prior explanation to the patient • Not to smoke /inhale bronchodilators 6 hrs prior or oral bronchodilators 12hrs prior. • Remove any tight clothings/ waist belt/ dentures • Pt. Seated comfortably If obese, child < 12 yrs- standing
  • 36. PREREQUISITES • Nose clip to close nostrils. • Exp. Effort shld last ≥ 4 secs. • Should not be interfered by coughing, glottic closure, mechanical obstruction. • 3 acceptable tracings taken & largest value is used.
  • 37. SPIROMETER • Double walled cylinder with water to maintain water tight seal • Inverted bell attached to pulley which carries a counterweight and pen – moves up and down as volume of bell changes • BREATHING ASSEMBLY i.E. Unidirectional breathing valves with mouth piece.
  • 38. Flow-Volume Curves and Spirograms • Two ways to record results of FVC maneuver: – Flow-volume curve---flow meter measures flow rate in L/s upon exhalation; flow plotted as function of volume – Classic spirogram---volume as a function of time
  • 39. Normal Flow-Volume Curve and Spirogram www.anaesthesia.co.in
  • 40. Spirometry Interpretation: So what constitutes normal? • Normal values vary and depend on: – Height – Age – Gender – Ethnicity
  • 41. Acceptable and Unacceptable Spirograms (from ATS, 1994) www.anaesthesia.co.in
  • 42. Measurements Obtained from the FVC Curve • FEV1---the volume exhaled during the first second of the FVC maneuver • FEF 25-75%---the mean expiratory flow during the middle half of the FVC maneuver; reflects flow through the small (<2 mm in diameter) airways • FEV1/FVC---the ratio of FEV1 to FVC X 100 (expressed as a percent); an important value because a reduction of this ratio from expected values is specific for obstructive rather than restrictive diseases
  • 43. Spirometry Interpretation: Obstructive vs. Restrictive Defect • Obstructive Disorders – Characterized by a limitation of expiratory airflow so that airways cannot empty as rapidly compared to normal (such as through narrowed airways from bronchospasm, inflammation, etc.) Examples: – Asthma – Emphysema – Cystic Fibrosis • Restrictive Disorders – Characterized by reduced lung volumes/decreased lung compliance Examples: – Interstitial Fibrosis – Scoliosis – Obesity – Lung Resection – Neuromuscular diseases – Cystic Fibrosis
  • 44. Normal vs. Obstructive vs. Restrictive (Hyatt, 2003)
  • 45. Spirometry Interpretation: Obstructive vs. Restrictive Defect • Obstructive Disorders – FVC nl or↓ – FEV1 ↓ – FEF25-75% ↓ – FEV1/FVC ↓ – TLC nl or ↑ • Restrictive Disorders – FVC ↓ – FEV1 ↓ – FEF 25-75% nl to ↓ – FEV1/FVC nl to ↑ – TLC ↓
  • 46. Spirometry Interpretation: What do the numbers mean? • FVC • Interpretation of % predicted: – 80-120% Normal – 70-79% Mild reduction – 50%-69% Moderate reduction – <50% Severe reduction FEV1 Interpretation of % predicted: – >75% Normal – 60%-75% Mild obstruction – 50-59% Moderate obstruction – <49% Severe obstruction
  • 47. Spirometry Interpretation: What do the numbers mean? • FEF 25-75% • Interpretation of % predicted: – >79% Normal – 60-79% Mild obstruction – 40-59% Moderate obstruction – <40% Severe obstruction • FEV1/FVC • Interpretation of absolute value: – 80 or higher Normal – 79 or lower Abnormal
  • 48. What about lung volumes and obstructive and restrictive disease?
  • 49. MEASUREMENTS OF VOLUMES • TLC, RV, FRC – MEASURED USING Nitrogen washout method Inert gas (helium) dilution method Total body plethysmography
  • 50. CONTINUED……….. 1) HELIUM DILUTION METHOD: Patient breathes in and out of a spirometer filled with 10% helium and 90% o2, till conc. In spirometer and lung becomes same (equilibirium). As no helium is lost; (as it is insoluble in blood) C1 X V1 = C2 ( V1 + V2) V2 = V1 ( C1 – C2) C2 V1= VOL. OF SPIROMETER V2= FRC C1= Conc.of He in the spirometer before equilibrium C2 = Conc, of He in the spirometer after equilibrium
  • 51. CONTINUED……… 2) TOTAL BODY PLETHYSMOGRAPHY: Subject sits in an air tight box. At the end of normal exhalation – shuttle of mouthpiece closed and pt. is asked to make resp. efforts. As subject inhales – expands gas volume in the lung so lung vol. increases and box pressure rises and box vol. decreases. BOYLE’S LAW: PV = CONSTANT (at constant temp.) For Box – p1v1 = p2 (v1- ∆v) For Subject – p3 x v2 =p4 (v2 - ∆v) P1- initial box pr. P2- final box pr. V1- initial box vol. ∆ v- change in box vol. P3- initial mouth pr., p4- final mouth pr. V2- FRC
  • 52. CONTINUED……… DIFFERENCE BETWEEN THE TWO METHODS: • In healthy people there is very little difference. • Gas dilution technique measures only the communicating gas volume. • Thus, • Gas trapped behind closed airways • Gas in pneumothorax • => are not measured by gas dilution technique, but measured by body plethysmograph
  • 53. CONTINUED……… 3) N2 WASH OUT METHOD: • Following a maximal expiration (RV) or normal expiration (FRC), Pt. inspires 100% O2 and then expires it into spirometer ( free of N2) → over next few minutes (usually 6-7 min.), till all the N2 is washed out of the lungs. N2 conc. of spirometer is calculated followed by total vol.of AIR exhaled. As air has 80% N2 → so actual FRC/RV is calculated.
  • 54. MEASUREMENT OF DYNAMIC LUNG VOLUMES • TIMED EXPIRED SPIROGRAMS FEF25–75% = forced expiratory flow during expiration of 25 to 75% of the FVC; FEV1 = forced expiratory volume in the first second of forced vital capacity maneuver; FVC = forced vital capacity (the maximum amount of air forcibly expired after maximum inspiration).
  • 55. FORCED VITAL CAPACITY (FVC) Max vol. Of air which can be expired out as forcefully and rapidly as possible, following a maximal inspiration to TLC.  Exhaled volume is recorded with respect to time.  Indirectly reflects flow resistance property of airways.  Normal healthy subjects have VC = FVC.  Prior instruction to patients, practice attempts as it needs patient cooperation and effect.  Exhalation should take at least 4 sec and should not be interrupted by cough, glottic closure or mechanical obstruction.
  • 56. FORCED VITAL CAPACITY IN 1 SEC. (FEV1) Forced expired vol. In 1 sec during fvc maneuver. Expressed as an absolute value or % of fvc. N- FEV1 (1 SEC)- 75-85% OF FVC  FEV2 (2 SEC)- 94% OF FVC  FEV3 (3 SEC)- 97% OF FVC
  • 57. CONTINUED…… CLINICAL RANGE (FEV1) • 3 - 4.5 L • 1.5 – 2.5 L • <1 L • 0.8 L • 0.5 L PATIENT GROUP • NORMAL ADULT • MILD – MOD.OBSTRUCTION • HANDICAPPED • DISABILITY • SEVERE EMPHYSEMA
  • 58. CONTINUED…… FEV1 – Decreased in both obstructive & restrictive lung disorders. FEV1/FVC – Reduced in obstructive disorders. NORMAL VALUE IS 75 – 85 % (FEV1/FVC) < 70% OF PREDICTED VALUE – MILD OBST. < 60% OF PREDICTED VALUE – MODERATE OBST. < 50% OF PREDICTED VALUE – SEVERE OBST.
  • 59. CONTINUED…… DISEASE STATES FVC FEV1 FEV1/FVC 1) OBSTRUCTIVE NORMAL ↓ ↓ 2) STIFF LUNGS ↓ ↓ NORMAL 3 ) RESP. MUSCLE WEAKNESS ↓ ↓ NORMAL
  • 60. PEAK EXPIRATORY FLOW RATE (PEFR) - It is the max. Flow rate during fvc maneuver in the initial 0.1 sec. -PEFR DETERMINED BY : 1) Function of caliber of airways 2) Expiratory muscle strength 3) Pt’s coordination & effort - Estimated by 1) drawing a tangent to steepest part of FVC spirogram (error prone) 2) average flow during the litre of gas expired after initial 200 ml during fvc maneuver. - .
  • 61. FORCED MID-EXPIRATORY FLOW RATE (FEF25%-75%): • Maximum Mid expiratory Flow rate • Max. Flow rate during the mid-expiratory part of FVC maneuver. • Effort independent • Misnomer, as FEF25-75% decreased by 1) marked reduction in exp. Effort 2)submaximal inspiration b4 maneuver → ↓FVC → ↓ FEF25- 75% • It may decrease with truly max. Effort as compared to slightly submaximal effort as dynamic airway compression occurs with maximal effort. • N value – 4.5-5 l/sec. Or 300 l/min. • Upto 2l/sec- acceptable. • CLINICAL SIGNIFICANCE: SENSITIVE & IST INDICATOR OF OBSTRUCTION OF SMALL DISTAL AIRWAYS
  • 62. MAXIMUM BREATHING CAPACITY: (MBC/MVV) • MAX. VOLUNTARY VENTILATION  Largest volume that can be breathed per minute by voluntary effort , as hard & as fast as possible.  N – 150-175 l/min.  Estimate of max. Ventilation available to meet increased physiological demand.  Measured for 12 secs – extrapolated for 1 min.  MVV = FEV1 X 35
  • 63. CONTINUED……. • Discrepancy b/w FEV1 and MVV means inconsistent / submaximal inspiratory effort • MBC/MVV altered by- airway resistance - Elastic property -Muscle strength - Learning - Coordination - Motivation
  • 64. RESPIRATORY MUSCLE STRENGTH Evaluated by measuring max. Static resp. Pressure with anaeroid gauge • Pressures are generated against occluded airway during a max. Forced insp/exp. Effort MAX STATIC INSP. PRESSURE: (PIMAX)- • Measured when inspiratory muscles are at their optimal length i.e. at RV • PI MAX = -125 CM H2O • CLINICAL SIGNIFICANCE:  IF PI MAX< 25 CM H2O – Inability to take deep breath.
  • 65. CONTINUED……. • MAX. STATIC EXPIRATORY PRESSURE (PEMAX):  Measured after full inspiration to TLC  N VALUE OF PEMAX IS =200 CM H20  PEMAX < +40 CM H20 – Impaired cough ability  Particularly useful in pts with NM Disorders during weaning
  • 66. MEASUREMENT OF AIRWAY RESISTANCE 1) Raw- Body plethysmography 2) Forced expiratory maneuvers:  Peak expiratory flow (PEF) FEV1 3) Response to bronchodialtors (FEV1)
  • 67. Spirometry Pre and Post Bronchodilator • Obtain a flow-volume loop. • Administer a bronchodilator. • Obtain the flow-volume loop again a minimum of 15 minutes after administration of the bronchodilator. • Calculate percent change (FEV1 most commonly used---so % change FEV 1= [(FEV1 Post-FEV1 Pre)/FEV1 Pre] X 100). • Reversibility is with 12% or greater change.
  • 68. FLOW VOLUME LOOPS • Do FVC maneuver and then inhale as rapidly and as much as able. • This makes an inspiratory curve. • The expiratory and inspiratory flow volume curves put together make a flow volume loop.
  • 70. How is a flow-volume loop helpful? • Helpful in evaluation of air flow limitation on inspiration and expiration • In addition to obstructive and restrictive patterns, flow- volume loops can show provide information on upper airway obstruction: – Fixed obstruction: constant airflow limitation on inspiration and expiration—such as in tumor, tracheal stenosis – Variable extrathoracic obstruction: limitation of inspiratory flow, flattened inspiratory loop—such as in vocal cord dysfunction – Variable intrathoracic obstruction: flattening of expiratory limb; as in malignancy or tracheomalacia
  • 71. TESTS FOR GAS EXCHANGE FUNCTION 1) ALVEOLAR-ARTERIAL O2 TENSION GRADIENT:  Sensitive indicator of detecting regional V/Q inequality  N value in young adult at room air = 8 mmhg to upto 25 mmhg in 8th decade (d/t decrease in PaO2)  AbN high values at room air is seen in asymptomatic smokers & chr. Bronchitis (min. symptoms) PAO2 = PIO2 – PaCo2 R
  • 72. CONTINUED…….. 2) DYSPNEA DIFFENRENTIATION INDEX (DDI): - To d/f dyspnea due to resp/ cardiac d’s DDI = PEFR x PaCO2 1000 - DDI- Lower in resp. pathology
  • 73. CONTINUED…… 3) DIFFUSING CAPACITY OF LUNG: defined as the rate at which gas enters into bld. divided by its driving pr. DRIVING PR: gradient b/w alveoli & end capillary tensions. Fick’s law of diffusion : Vgas = A x D x (P1-P2) T D= diffusion coeff= solubility √MW
  • 74. CONTINUED……. • DL IS MEASURED BY USING CO, COZ: A) High affinity for Hb which is approx. 200 times that of O2 , so does not rapidly build up in plasma B) Under N condition it has low bld conc ≈ 0 C) Therefore, pulm conc.≈0
  • 75. SINGLE BREATH TEST USING CO • Pt inspires a dilute mixture of CO and hold the breath for 10 secs. • CO taken up is determined by infrared analysis: • DlCO = CO ml/min/mmhg • PACO – PcCO • N range 20- 30 ml/min./mmhg. • DLO2 = DLCO x 1.23
  • 76. DLCO decreases in- • Emphysema, lung resection, pul. Embolism, anaemia • Pulmonary fibrosis, sarcoidosis- increased thickness • DLCO increases in: (Cond. Which increase pulm, bld flow)  Supine position  Exercise  Obesity  L-R shunt
  • 77. TESTS FOR CARDIOPLULMONARY INTERACTIONS • Reflects gas exchange, ventilation, tissue O2, CO. • QUALITATIVE- history, exam, ABG, stair climbing test • QUANTITATIVE- 6 minute walk test
  • 78. CONTINUED……. • 1) STAIR CLIMBING TEST: • If able to climb 3 flights of stairs without stopping/dypnoea at his/her own pace- ↓ed morbidity & mortality • If not able to climb 2 flights – high risk • 2) 6 MINUTE WALK TEST: - Gold standard - C.P. reserve is measured by estimating max. O2 uptake during exercise - Modified if pt. can’t walk – bicycle/ arm exercises - If pt. is able to walk for >2000 feet during 6 min pd, - VO2 max > 15 ml/kg/min - If 1080 feet in 1 min : VO2 of 12ml/kg/min - Simultaneously oximetry is done & if Spo2 falls >4%- high risk